Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles. - Wikidata - awgldk - TriplyDB

Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.

Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.

http://www.wikidata.org/entity/Q37073299

about

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)Developments in L2-based human papillomavirus (HPV) vaccines.Recent advances in preclinical model systems for papillomaviruses.Human papillomavirus 16L1-58L2 chimeric virus-like particles elicit durable neutralizing antibody responses against a broad-spectrum of human papillomavirus types.Broadly neutralizing antiviral responses induced by a single-molecule HPV vaccine based on thermostable thioredoxin-L2 multiepitope nanoparticles.Minor capsid protein L2 polytope induces broad protection against oncogenic and mucosal human papillomaviruses.Displaying 31RG-1 peptide on the surface of HPV16 L1 by use of a human papillomavirus chimeric virus-like particle induces cross-neutralizing antibody responses in mice.

P2860

Q36240497-65A753D2-A2AB-440B-9CF5-BE763848B545 Q39021001-8FF8E14B-DA6F-4DD2-9616-5CBA39B6F751 Q39036718-DE2F172E-CF3C-4376-A89B-228B197DC80B Q41926367-3DB03259-8E10-4263-A237-7916FFDC6AEA Q47110564-2A1A3BD6-20A9-4C0F-87C4-142476ED4392 Q47322093-2B52273E-A68F-4874-8D47-C2F7E3A60AA2 Q52312756-80C6CC3B-792D-4936-97B3-289A76723D36

P2860

Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.

http://www.wikidata.org/entity/Q37073299

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Broad Cross-Protection Is Indu ...... Chimeric Virus-Like Particles.

@en

Broad Cross-Protection Is Indu ...... Chimeric Virus-Like Particles.

@nl

type

label

Broad Cross-Protection Is Indu ...... Chimeric Virus-Like Particles.

@en

Broad Cross-Protection Is Indu ...... Chimeric Virus-Like Particles.

@nl

prefLabel

Broad Cross-Protection Is Indu ...... Chimeric Virus-Like Particles.

@en

Broad Cross-Protection Is Indu ...... Chimeric Virus-Like Particles.

@nl

P1433

Q37073299-9CF2029E-EE98-4D4C-BCB0-3253D3914C2B

P1476

Q37073299-F41783C6-5780-4111-B95F-F5BB1AFE068D

P2093

Q37073299-0F0847AC-A732-4397-8614-6C94689F4C4F

Q37073299-12193BF0-574F-4848-8787-F3A52DD55626

Q37073299-13684D48-AC1A-43F2-95AF-85E755A2244F

Q37073299-1ED649CA-9BA6-4B56-A231-2A29B0F49A2A

Q37073299-4B7DC353-40F9-4AED-9F87-C8E782843620

Q37073299-5DD2CD8F-4E91-4388-AA90-19E7943A3B9C

Q37073299-6C4E587B-D9C5-4BBC-BD40-8A9DE4C7AC0E

Q37073299-86A4CB84-7F7E-4B0B-BA1D-FF40386A8FA9

Q37073299-F2ECB456-2020-4ACE-B4DA-BC48FCCC1087

P2860

Q37073299-04C5CEB8-69B4-4114-883C-78D822845B6D

Q37073299-0DB738C6-0E0E-4C13-856E-785E37D93F1D

Q37073299-0E4AD979-1C4B-4B7A-98FE-3521BC962653

Q37073299-1235C092-CCDF-4821-A710-8077930AA97A

Q37073299-159E9C88-BD36-4D51-BAED-1DE335FB32F7

Q37073299-171B1E6A-A457-42F0-B725-C959A2D2D9C7

Q37073299-20DF728B-EAFB-4FC1-9294-B19BBCB299F5

Q37073299-256B38CF-D940-415F-A3D5-FD3389CA48CF

Q37073299-25B3FE7E-B9AD-4DFE-91F5-7920B2823D5A

Q37073299-280C5290-987A-472A-B9D1-D22F3C20108F

P304

Q37073299-B9359F35-21BB-4FF2-A804-EECACC87B618

P31

Q37073299-BCAFE340-80FC-40D6-B5F6-380C0FD4A7FE

P356

Q37073299-F9DF810C-F323-48BB-86D3-E748F7BBE956

P407

Q37073299-5E513A47-285B-47F3-ACEA-A3288DE5C551

P433

Q37073299-EEBE6805-B71E-4662-91F7-833B194D4759

P478

Q37073299-943C017F-0A4D-436C-A7C8-F3D1A4AC362E

P577

Q37073299-4C8AB406-A665-4DC6-BB7B-1864F63E2DDA

P698

Q37073299-A82EA550-B97C-4007-85C4-252022CEE860

P932

Q37073299-3A1487D7-90E8-4917-A63E-95E4492FB943

P356

P1433

Journal of Virology

P1476

Broad Cross-Protection Is Indu ...... Chimeric Virus-Like Particles.

@en

P2093

Agnès Miseur

http://www.w3.org/2001/XMLSchema#string

Emmanuel Mertens

http://www.w3.org/2001/XMLSchema#string

Karla K Balogh

http://www.w3.org/2001/XMLSchema#string

Mathieu Boxus

http://www.w3.org/2001/XMLSchema#string

Michel Fochesato

http://www.w3.org/2001/XMLSchema#string

Najoua Dendouga

http://www.w3.org/2001/XMLSchema#string

Neil D Christensen

http://www.w3.org/2001/XMLSchema#string

Sandra L Giannini

http://www.w3.org/2001/XMLSchema#string

Sarah Brendle

http://www.w3.org/2001/XMLSchema#string

P2860

Atomic model of the papillomavirus capsid

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes

A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

P304

6314-6325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00449-16

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27147749

http://www.w3.org/2001/XMLSchema#string

P932

4936133

http://www.w3.org/2001/XMLSchema#string